Viewing nowCombinationBaropozine 10/160 mg
Valsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Daehwa Pharmaceutical Co., Ltd.

MFDS item code 201309069 · Approved 2013.08.29 · Insurance code 645604160
Treatment of essential hypertension not controlled with monotherapy
This medication helps effectively lower blood pressure in patients with essential hypertension who have difficulty controlling their blood pressure with either amlodipine or valsartan alone. The combination of the two drugs dilates blood vessels and reduces the burden on the heart, allowing for stable blood pressure management. This contributes to reducing the risk of cardiovascular complications and maintaining a healthier state. This medication is used in the treatment of essential hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, as described below, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or more); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Those allergic to the active ingredients or similar components, pregnant women or women who may become pregnant, and breastfeeding women should not take this medication. Patients with severe kidney or liver dysfunction, or those with a history of certain heart diseases or angioedema should consult a doctor before using this medication. Patients with low sodium or fluid levels in the body should improve their condition before taking this medication, and should carefully monitor for symptoms of blood pressure reduction during treatment. Patients with high potassium levels should frequently check their potassium levels when taking this medication along with potassium supplements or potassium-sparing diuretics. Patients who have undergone kidney transplantation or have heart failure or post-myocardial infarction should closely monitor their kidney function and heart condition while taking this medication, and special caution is required for some patients with heart diseases. This medication may increase the risk of low blood pressure, kidney function decline, and hyperkalemia when used in combination with some other antihypertensive drugs, so consult a doctor about concomitant medications. Caution is needed as dizziness or fatigue may occur when driving or operating machinery. The ingredients of this medication may be excreted in breast milk, so breastfeeding women are advised to avoid taking it. The safety and efficacy of this medication have not been sufficiently established in children under 18, so it is not recommended for use in this age group. Elderly patients can take the general dosage but should follow the doctor's instructions according to their individual condition. Overdosage may cause severe hypotension or heart function decline, so it is important to avoid exceeding the dosage and seek medical assistance immediately if any unusual symptoms occur.
Nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, orthostatic dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, diaphoresis, rash, itching, joint swelling, low back pain, arthritis, muscle cramps, lethargy, polyuria, nocturia, erectile dysfunction, edema, peripheral edema, facial edema, generalized edema, fatigue, flushing, weakness, facial flushing, decrease in hemoglobin, decrease in hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory reduction, taste alteration, peripheral neuropathy, myotonia, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival overgrowth, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, dysuria, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, nervousness, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent air or moisture ingress. It is best stored at room temperature between 1°C and 30°C, avoiding extremely hot or cold places.
Bright yellow rectangular film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Daehwa Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.